The analysis indicated that the proportion of CD4+CD25+FOXP3+ Tregs and FOXP3 expression were significantly increased in SSc CD4+ T cells after ATRA alone treatment or ATRA and TGF-β combined treatment. The gene discussed is TGFB1; the disease is systemic sclerosis.